Redsense Medical AB (publ)

NGM:REDS Stock Report

Market Cap: SEK 117.7m

Redsense Medical Past Earnings Performance

Past criteria checks 0/6

Redsense Medical has been growing earnings at an average annual rate of 0.5%, while the Medical Equipment industry saw earnings growing at 22.9% annually. Revenues have been growing at an average rate of 10.9% per year.

Key information

0.5%

Earnings growth rate

3.2%

EPS growth rate

Medical Equipment Industry Growth6.2%
Revenue growth rate10.9%
Return on equity-17.8%
Net Margin-25.8%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Here's Why We're Watching Redsense Medical's (NGM:REDS) Cash Burn Situation

Jun 15
Here's Why We're Watching Redsense Medical's (NGM:REDS) Cash Burn Situation

Redsense Medical (NGM:REDS) Is In A Good Position To Deliver On Growth Plans

Mar 01
Redsense Medical (NGM:REDS) Is In A Good Position To Deliver On Growth Plans

We're Not Very Worried About Redsense Medical's (NGM:REDS) Cash Burn Rate

Nov 10
We're Not Very Worried About Redsense Medical's (NGM:REDS) Cash Burn Rate

Is Redsense Medical (NGM:REDS) In A Good Position To Deliver On Growth Plans?

Apr 20
Is Redsense Medical (NGM:REDS) In A Good Position To Deliver On Growth Plans?

Shareholders Are Thrilled That The Redsense Medical (NGM:REDS) Share Price Increased 236%

Feb 24
Shareholders Are Thrilled That The Redsense Medical (NGM:REDS) Share Price Increased 236%

Revenue & Expenses Breakdown

How Redsense Medical makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

NGM:REDS Revenue, expenses and earnings (SEK Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2424-6200
30 Jun 2424-4190
31 Mar 2420-8180
31 Dec 2326-5180
30 Sep 2326-6200
30 Jun 2322-8210
31 Mar 2319-7220
31 Dec 2217-9220
30 Sep 2213-7220
30 Jun 2219-7240
31 Mar 2216-8210
31 Dec 2116-8230
30 Sep 2115-13230
30 Jun 2111-14200
31 Mar 2117-11210
31 Dec 2017-9170
30 Sep 2018-5140
30 Jun 2020-2140
31 Mar 2017-4130
31 Dec 1914-5130
30 Sep 1912-6110
30 Jun 1911-6110
31 Mar 199-6110
31 Dec 189-7110
30 Sep 187-7110
30 Jun 184-8110
31 Mar 184-8100
31 Dec 172-990
30 Sep 174-890
30 Jun 175-7100
31 Mar 175-690
31 Dec 166-580
30 Sep 164-570
30 Jun 162-550
31 Mar 162-450
31 Dec 152-340
30 Sep 152-340
30 Jun 153-340
31 Mar 152-330
31 Dec 142-230
31 Dec 132-340

Quality Earnings: REDS is currently unprofitable.

Growing Profit Margin: REDS is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: REDS is unprofitable, but has reduced losses over the past 5 years at a rate of 0.5% per year.

Accelerating Growth: Unable to compare REDS's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: REDS is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (31%).


Return on Equity

High ROE: REDS has a negative Return on Equity (-17.81%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 10:33
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Redsense Medical AB (publ) is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Maria Karlsson OsipovaPenser Access